<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.credenceresearch.com/news/valero-acquire-lyondellbasell-houston-refinery-restart-165000-bpd-2027</loc>
    <news:news>
      <news:publication>
        <news:name>Credence Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-02T03:10:37.000Z</news:publication_date>
      <news:title>Valero to Buy LyondellBasell&apos;s Idled Houston Refinery, Restart 165,000 b/d by End-2027</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.credenceresearch.com/news/fda-approves-inovio-voceryq-first-plasmid-dna-immunotherapy-recurrent-respiratory-papillomatosis</loc>
    <news:news>
      <news:publication>
        <news:name>Credence Research</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-02T01:02:37.000Z</news:publication_date>
      <news:title>FDA Approves Inovio&apos;s Voceryq, First Plasmid DNA Immunotherapy, for Recurrent Respiratory Papillomatosis</news:title>
    </news:news>
  </url>
</urlset>
